Orrstown Financial Services Inc Abb Vie Inc. Transaction History

Orrstown Financial Services Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $21,855 - $27,345	-303 Closed	0 $0
Q2 2019 Jul 11, 2019	BUY	$65.7 - $83.98 $19,907 - $25,445	303 New	303 $22,000
Q1 2019 Apr 04, 2019	SELL	$77.14 - $90.79 $20,056 - $23,605	-260 Closed	0 $0
Q4 2018 Jan 25, 2019	BUY	$77.85 - $96.01 $20,241 - $24,962	260 New	260 $24,000

3,653

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Orrstown Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Orrstown Financial Services Inc with notifications on news.